So far your response to this survey request has been disappointing.
The Health innovation fund (jointly funded The Wellcome Trust and Department of Health) have put out a specifically commissioned call for repurposing of medicines
As a British MSer. This could affect you!.
Should Neuros spend/waste their time trying to get repurposed drugs on the agenda for progressive MSers, etc. or Leave it to Pharma to decide whether they can or cannot find a target to treat your MS.
It takes a lot of effort to get studies off the ground and supported. The MS-SMART trials (See research day video by Sir Jeremy) for progressive MS have been over 5 years in the planning and this is just for the trials, which have yet to get off the ground. How would they become licensed drugs is another issue. Has this been thought through
As a non-Brit MSer it could affect you also!.
Although the circumstance are somewhat different to other countries because of the Naional Health Service in the UK, once a drug gets a licence in one country, it is going to be easier to get a licence in another country, especially within Europe.
There are loads more questions for and against this path. I have my views. What are your views?
See Prof G post on off label prescribing